Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 51, 1996 - Issue 4
1
Views
4
CrossRef citations to date
0
Altmetric
Original articles

In Vitro Susceptibilities of 180 Clinical Isolates of Haemophilus Influenzae to Ampicillin, Amoxycillin/Clavulanate, Cefaclor, Cefuroxime, Cefotaxime, Clarithromycin, and Azithromycin

, , , , , , , , , & show all
Pages 237-243 | Published online: 16 May 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Glen T Hansen, Kelli L Metzler, Emidio DeCarolis & Joseph M Blondeau. (2002) The macrolides. Expert Opinion on Investigational Drugs 11:2, pages 189-215.
Read now

Articles from other publishers (3)

Johan Flamaing, Daniël Knockaert, Björn Meijers, Jan Verhaegen & Willy E. Peetermans. (2013) Sequential therapy with cefuroxime and cefuroxime-axetil for community-acquired lower respiratory tract infection in the oldest old. Aging Clinical and Experimental Research 20:1, pages 81-86.
Crossref
Jasjit Singh, Bill Burr, Del Stringham & Antonio Arrieta. (2001) Commonly Used Antibacterial and Antifungal Agents for Hospitalised Paediatric Patients. Paediatric Drugs 3:10, pages 733-761.
Crossref
Peter Cole. (1997) Pharmacologic and clinical comparison of cefaclor in immediate-release capsule and extended-release tablet forms. Clinical Therapeutics 19:4, pages 617-625.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.